Table of contents
March 2009, Volume 27 No 3 pp226-296
- In This Issue
- Bioentrepreneur
- Editorial
- News
- Opinion and Comment
- Features
- News and Views
- Computational Biology
- Research
- Naturejobs
Editorial
A balancing act - p209
doi:10.1038/nbt0309-209
Contrary to Genentech's claims, turning over all in vitro diagnostics to the US Food and Drug Administration (FDA) is the wrong approach to achieve better clinical validation of tests.
Abstract - | Full Text - A balancing act | PDF (112 KB) - A balancing act
News
Comparative effectiveness casts first shadows across US industry - pp211 - 212
Emily Waltz
doi:10.1038/nbt0309-211
Full Text - Comparative effectiveness casts first shadows across US industry | PDF (2,815 KB) - Comparative effectiveness casts first shadows across US industry
Genentech grapples with direct offer - p212
Brady Huggett
doi:10.1038/nbt0309-212
Full Text - Genentech grapples with direct offer | PDF (1,093 KB) - Genentech grapples with direct offer
Geron gets green light for human trial of ES cell–derived product - pp213 - 214
Joe Alper
doi:10.1038/nbt0309-213a
Full Text - Geron gets green light for human trial of ES cell–derived product | PDF (919 KB) - Geron gets green light for human trial of ES cell–derived product
Alnylam dealt blow - p213
Asher Mullard
doi:10.1038/nbt0309-213b
Full Text - Alnylam dealt blow | PDF (903 KB) - Alnylam dealt blow
C-Path sets diagnostics standard - p213
Jim Roberts
doi:10.1038/nbt0309-213c
Full Text - C-Path sets diagnostics standard | PDF (903 KB) - C-Path sets diagnostics standard
Vatican cheers GM - p214
Anna Meldolesi
doi:10.1038/nbt0309-214a
Full Text - Vatican cheers GM | PDF (69 KB) - Vatican cheers GM
China overhauls patent law - p214
Jane Qiu
doi:10.1038/nbt0309-214b
Full Text - China overhauls patent law | PDF (69 KB) - China overhauls patent law
Report blames NICE for hastening decline of UK biotech - pp215 - 217
Nuala Moran
doi:10.1038/nbt0309-215
Full Text - Report blames NICE for hastening decline of UK biotech | PDF (748 KB) - Report blames NICE for hastening decline of UK biotech
Norway's swift bail out - p216
Nayanah Siva
doi:10.1038/nbt0309-216a
Full Text - Norway's swift bail out | PDF (700 KB) - Norway's swift bail out
Green fuels thrust - p216
Victor Bethencourt
doi:10.1038/nbt0309-216b
Full Text - Green fuels thrust | PDF (700 KB) - Green fuels thrust
Pfizer swallows Wyeth, validates niche buster - pp218 - 219
Cormac Sheridan
doi:10.1038/nbt0309-218
Full Text - Pfizer swallows Wyeth, validates niche buster | PDF (829 KB) - Pfizer swallows Wyeth, validates niche buster
Profile
Willem 'Pim' Stemmer - p220
Crispin Littlehales
doi:10.1038/nbt0309-220
One of the most pioneering protein engineers of his generation is also a serial entrepreneur with a flair for spotting new business opportunities.
Abstract - | Full Text - Willem 'Pim' Stemmer | PDF (376 KB) - Willem 'Pim' Stemmer
Data Page
13.3 million farmers cultivate GM crops - p221
Andrew Marshall
doi:10.1038/nbt0309-221
Full Text - 13.3 million farmers cultivate GM crops | PDF (338 KB) - 13.3 million farmers cultivate GM crops
News Feature
Fresh from the biologic pipeline - pp222 - 225
Randall Osborne
doi:10.1038/nbt0309-222
Randy Osborne reports on the latest product approvals.
Abstract - | Full Text - Fresh from the biologic pipeline | PDF (223 KB) - Fresh from the biologic pipeline
Bioentrepreneur
Building a business
When times get tough - pp226 - 228
Simcha Jong
doi:10.1038/bioe.2009.1
Opinion and Comment
Correspondence
A survey of South-North health biotech collaboration - pp229 - 232
Christina C. Melon, Monali Ray, Sharon Chakkalackal, Michelle Li, Jan E. Cooper, Jennifer Chadder, Wen Ke, Lexuan Li, Magdy A. Madkour, Sahar Aly, Nefertiti Adly, Sachin Chaturvedi, Victor Konde, Abdallah S. Daar, Peter A. Singer & Halla Thorsteinsdóttir
doi:10.1038/nbt0309-229
Full Text - A survey of South-North health biotech collaboration | PDF (1,204 KB) - A survey of South-North health biotech collaboration | Supplementary information
BIO and the next generation - p232
Jim Greenwood
doi:10.1038/nbt0309-232
Full Text - BIO and the next generation | PDF (387 KB) - BIO and the next generation
Bonsai biotech - p233
William Bains
doi:10.1038/nbt0309-233
Commentary
Proliferation-resistant biotechnology: an approach to improve biological security - pp234 - 236
Ali Nouri & Christopher F Chyba
doi:10.1038/nbt0309-234
Is there a way to design DNA synthesis technology with safeguards that prevent its cooption for nefarious purposes?
Abstract - | Full Text - Proliferation-resistant biotechnology: an approach to improve biological security | PDF (385 KB) - Proliferation-resistant biotechnology: an approach to improve biological security
Features
Biotech under Barack - pp237 - 244
Jeffrey L Fox
doi:10.1038/nbt0309-237
The Obama administration looks to be a welcome shot in the arm for the scientific endeavor, but the current economic crisis is likely to keep several issues of key interest to biotech firmly on the back burner.
Abstract - | Full Text - Biotech under Barack | PDF (486 KB) - Biotech under Barack
Patents
Bilski blundering biotech - pp245 - 248
William J Simmons
doi:10.1038/nbt0309-245
Is the Federal Circuit's decision in In re: Bilski yet a further restraint on patenting biotech and pharmaceutical inventions?
Abstract - | Full Text - Bilski blundering biotech | PDF (191 KB) - Bilski blundering biotech
Recent patent applications in RNA interference - p249
doi:10.1038/nbt0309-249
Full Text - Recent patent applications in RNA interference | PDF (61 KB) - Recent patent applications in RNA interference
News and Views
A splicing component adapted to gene silencing - pp250 - 251
Xavier Roca & Adrian R Krainer
doi:10.1038/nbt0309-250
U1 adaptors offer an alternative to siRNA for targeted gene knockdown.
Abstract - | Full Text - A splicing component adapted to gene silencing | PDF (153 KB) - A splicing component adapted to gene silencing
See also: Research by Goraczniak et al.
Jump-starting cancer gene discovery - pp251 - 252
Anthony Uren & Anton Berns
doi:10.1038/nbt0309-251
Targeting transposon mutagenesis to a specific tissue facilitates screening for tumor-associated genes and tracking of tumor lineages.
Abstract - | Full Text - Jump-starting cancer gene discovery | PDF (385 KB) - Jump-starting cancer gene discovery
See also: Research by Keng et al.
Combinatorial stem cell mobilization - pp252 - 253
Mikhail G Kolonin & Paul J Simmons
doi:10.1038/nbt0309-252
Different subsets of bone marrow stem cells can be mobilized by varying drug treatments.
Abstract - | Full Text - Combinatorial stem cell mobilization | PDF (659 KB) - Combinatorial stem cell mobilization
Research highlights - p254
doi:10.1038/nbt0309-254
Full Text - Research highlights | PDF (168 KB) - Research highlights
Computational Biology
Primer
Maximizing power in association studies - pp255 - 256
Eran Halperin & Dietrich A Stephan
doi:10.1038/nbt0309-255
Only a subset of genetic variants can be examined in genome-wide surveys for genetic risk factors. How can a fixed set of markers account for the entire genome by acting as proxies for neighboring associations?
Abstract - | Full Text - Maximizing power in association studies | PDF (290 KB) - Maximizing power in association studies
Research
Articles
Gene silencing by synthetic U1 Adaptors - pp257 - 263
Rafal Goraczniak, Mark A Behlke & Samuel I Gunderson
doi:10.1038/nbt.1525
Goraczniak et al. introduce a gene-silencing method that uses 'U1 adaptors' to block polyadenylation of pre-mRNA in the nucleus. Silencing is stronger when U1 adaptors are combined with siRNAs than when either is used alone.
Abstract - | Full Text - Gene silencing by synthetic U1 Adaptors | PDF (479 KB) - Gene silencing by synthetic U1 Adaptors | Supplementary information
See also: News and Views by Roca & Krainer
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma - pp264 - 274
Vincent W Keng, Augusto Villanueva, Derek Y Chiang, Adam J Dupuy, Barbara J Ryan, Ilze Matise, Kevin A T Silverstein, Aaron Sarver, Timothy K Starr, Keiko Akagi, Lino Tessarollo, Lara S Collier, Scott Powers, Scott W Lowe, Nancy A Jenkins, Neal G Copeland, Josep M Llovet & David A Largaespada
doi:10.1038/nbt.1526
Keng et al. characterize the mouse hepatocellular carcinoma genome by using tissue-specific recombinase expression to restrict mobilization of the Sleeping Beauty transposon to the liver. High throughput sequencing of >100,000 insertions sites in mouse tumor nodules identifies potential therapeutic targets.
Abstract - | Full Text - A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma | PDF (1,143 KB) - A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma | Supplementary information
See also: News and Views by Uren & Berns
Letters
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling - pp275 - 280
Stuart M Chambers, Christopher A Fasano, Eirini P Papapetrou, Mark Tomishima, Michel Sadelain & Lorenz Studer
doi:10.1038/nbt.1529
Chambers et al. present an improved method for neural differentiation of human pluripotent stem cells that avoids the use of stromal feeder cells and embryoid bodies. By combining two inhibitors of SMAD signaling, the protocol generates neural cells with an efficiency of >80%.
First Paragraph - | Full Text - Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | PDF (683 KB) - Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Supplementary information
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells - pp281 - 287
Barak Blum, Ori Bar-Nur, Tamar Golan-Lev & Nissim Benvenisty
doi:10.1038/nbt.1527
Teratoma formation is a safety concern for any therapeutic strategy involving human embryonic stem cells. Blum et al. characterize teratomas derived from mouse and human embryonic stem cells and uncover a key role for the oncofetal gene survivin.
First Paragraph - | Full Text - The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells | PDF (671 KB) - The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells | Supplementary information
Autocatalytic aptazymes enable ligand-dependent exponential amplification of RNA - pp288 - 292
Bianca J Lam & Gerald F Joyce
doi:10.1038/nbt.1528
Lam and Joyce describe a new approach to ligand detection based on two cross-replicating RNA ligases with allosteric ligand-binding domains. The ligases amplify exponentially at a rate dependent on ligand concentration—a system analogous to qPCR for detection of small molecules and proteins.
First Paragraph - | Full Text - Autocatalytic aptazymes enable ligand-dependent exponential amplification of RNA | PDF (306 KB) - Autocatalytic aptazymes enable ligand-dependent exponential amplification of RNA | Supplementary information
Naturejobs
Careers and Recruitment
Biotech scientists bank on big pharma's biologics push - pp293 - 295
Grace Wong
doi:10.1038/nbt0309-293
Biologics represent a new hope for big pharma and new dreams for biotech scientists.
Abstract - | Full Text - Biotech scientists bank on big pharma's biologics push | PDF (789 KB) - Biotech scientists bank on big pharma's biologics push



